Caerus Investment Advisors, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1862682
WEST LAKE HILLS, TX
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$253,332
New position
Shares Held
510
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,305
of 1,735 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caerus Investment Advisors, LLC holds $2,970,774 across 10 Biotechnology names. VRTX ranks #5 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,349 | $841,155 | |
| 2 | INCY |
Incyte Corp
|
5,422 | $614,637 | |
| 3 | CYTK |
Cytokinetics Inc
|
6,000 | $511,140 | |
| 4 | EXEL |
Exelixis, Inc.
|
7,318 | $398,172 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
510 | $253,332 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,073 | $233,057 | |
| 7 | MNKD |
Mannkind Corp
|
11,129 | $47,409 | |
| 8 | FATE |
Fate Therapeutics Inc
|
16,037 | $43,299 |
All Filings in VRTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $253,332 | 510 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||